Natalie Johnston
Principal at 4BIO Capital
Natalie Johnston
Principal at 4BIO Capital
Greater London, England
Overview
Work Experience
Principal
2024 - Current
Associate
2022 - 2024
Investment Analyst
2019 - 2021
4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector.
Board Observer
2023
Research Manager
2018 - 2019
Senior Research Associate | Healthcare
2017 - 2018
GLG (Gerson Lehrman Group, Inc.) is the world’s leading platform for professional learning. Business leaders, investors, consultants, social entrepreneurs, and other top professionals rely on GLG to learn in short- and long-term engagements from more than 425,000 members and other experts. Clients partner with GLG to address their most complex strategic challenges, make better business decisions, and advance their careers through conversations, mentorships, small group convenings, surveys, and other interactions—all within a rigorous compliance framework. Global, technology-driven, and nimble, GLG’s approximately 1,200 employees work in 22 offices in 12 countries.
Research Associate | Healthcare
2016 - 2017
Biochemical Society Studentship
2012 - 2012
Awarded the Summer Vacation Studentship by the Biochemical Society U.K. - Completed a 6-week summer research project entitled ‘The functional anti-inflammatory consequences of AMPK activation in adipocytes’ under the supervision of Dr. Ian Salt, Institute of Cardiovascular & Medical Sciences, University of Glasgow. - Aimed to define whether AMPK activation in 3T3-L1 adipocytes alters MCP-1 secretion. - Project techniques: Mammalian cell culture and differentiation of adipocytes and macrophages, preparation of cell lysates, TCA precipitation of proteins, SDS-PAGE and immunoblotting and Chemotaxis assays. - Key skills learnt: Time-keeping and lab organisation, Image J computer programme, Adobe Photoshop, Microsoft Excel programming for statistical analysis.
Education
Doctor of Philosophy (Ph.D.)
2013 - 2016
Bachelor's Degree
2009 - 2013